SEC Form 4 · accession 0001209191-16-137786
SURMODICS INC · SRDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles W Olson
Officer — Senior VP & GM, Med Dev
Period of report
Aug 16, 2016
Accepted (ET)
Aug 18, 2016 · 4:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000924717
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 16, 2016 | S | 4,383 | $29.1759 | D | 33,098 | D | |
| Common StockF2 | Aug 16, 2016 | S | 1,528 | $29.0195 | D | 31,570 | D | |
| Common Stock | Aug 17, 2016 | S | 1,000 | $29.00 | D | 30,570 | D | |
| Common StockF3 | Aug 17, 2016 | S | 2,000 | $28.6485 | D | 28,570 | D | |
| Common StockF4 | Aug 17, 2016 | S | 1,025 | $28.6713 | D | 27,545 | D | |
| Common Stock | holding | — | — | — | 800 | I | By IRA |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reflects the weighted average price of 4,383 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on August 16, 2016 with sale prices ranging from $29.10 to $29.39 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F2Reflects the weighted average price of 1,528 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on August 16, 2016 with sale prices ranging from $29.00 to $29.043 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3Reflects the weighted average price of 2,000 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on August 17, 2016 with sale prices ranging from $28.55 to $29.02 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4Reflects the weighted average price of 1,025 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on August 17, 2016 with sale prices ranging from $28.51 to $28.75 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.